Not sure where to start? Get matched →
All of BPC-157 + TB-500 (Injectable)
BPC-157 + TB-500 (Injectable) in Nevada — pepti Pen
Popular
Nevada

BPC-157 + TB-500 (Injectable) in Nevada

Doctor-prescribed BPC-157 + TB-500 (Injectable) for Nevada residents. Reviewed by licensed Nevada physicians, compounded at FDA-registered pharmacies, and shipped to your door.

The pepti Pen cartridge for this treatment is sold out right now. The vial is the same medication at our best price.

All-in monthly price

$259

No membership fee · this is the full price · free shipping · avg 4-week supply

Medication, provider care, labs & dose adjustments — all in one price.
~28-day supply. Your provider sets your exact dose, so yours may vary — your refill arrives as you finish the last one.
Start assessment

Add in-depth bloodwork

Optional — add a physician-reviewed at-home blood panel to your plan.

At-home kit (1 device)+$149

Your sex-hormone baseline plus the safety markers that matter on therapy — blood counts, liver and kidney function — from one painless upper-arm device. Matched to your sex (PSA for men; progesterone & FSH for women). No needle, no clinic, physician-reviewed.

Money-back guarantee
Free AI care assistant
HSA/FSA accepted
Cancel anytime
Free shipping

This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.

Dr. Gene
Physician Reviewed

Reviewed by Dr. Gene, MD · Board-certified Family Medicine

Every Pepti prescription is reviewed by a licensed U.S. physician before it's dispensed — and only provided if clinically appropriate.

The process

How it works in Nevada

  1. 1Complete a free online intake (~5 minutes).
  2. 2A licensed Nevada physician reviews your case within 24 hours.
  3. 3Your prescription ships from our FDA-registered compounding pharmacy.
  4. 4Free shipping arrives 2–4 business days later. Refills ship automatically when your supply runs out — cancel anytime.
The treatment

What BPC-157 + TB-500 (Injectable) does

Our most popular stack combines BPC-157 with Thymosin Beta-4 for accelerated healing.

✓Enhanced tissue repair
✓Faster recovery
✓Injury prevention
✓Mobility support
Formulation
Injectable vial5 mL · 1 mg/mL each
BPC-1575 mg
TB-5005 mg
Pepti Pen cartridge3 mL cartridge (300 units)
BPC-1579 mg
TB-50013.5 mg

Amounts shown are per unit. Compounded fresh at a US FDA-registered pharmacy.

Quality

Every batch independently tested

Every medication batch dispensed through Pepti is independently tested by a qualified third-party laboratory for applicable quality and safety standards before the pharmacy releases it. Batches are tested to the same standard used by 503B outsourcing facilities.

Sterility

USP <71>

Confirms the finished preparation is free of viable microorganisms.

Bacterial endotoxins

USP <85>

Screens for endotoxins that can cause fever or inflammatory reactions.

Potency

Assay

Verifies the labeled concentration of the active peptide is what is in the vial.

Purity

HPLC

Checks the active peptide against impurities and degradation products.

Identity

Mass spectrometry

Confirms the peptide in the vial is the correct molecule.

pH

USP <791>

Confirms the solution sits within the range specified for injection.

Particulate matter

USP <788>

Checks the finished vial for visible and sub-visible particles.

Container closure integrity

USP <1207>

Confirms the vial seal holds so sterility is maintained through the beyond-use date.

Recent lots

  • Lot 1634586

    Tested 2026-09-02 · Eagle Analytical Services Inc.

    Sterility

    Pass

    Endotoxin

    5.06 EU/mL

    Potency

    100.9%

Compounded by licensed U.S. pharmacies. Prescribed by licensed medical providers. Shipped directly to patients in Nevada.Documentation available upon request →View lab results by lot →
Nevada

Telemedicine in Nevada.

Nevada permits telehealth prescribing by Nevada-licensed physicians under state telehealth law. Online intake review establishes the physician-patient relationship — no in-person visit is required for non-controlled medications. Pepti is available in all 50 states and Washington, D.C.

Las Vegas-area patients drive strong demand for performance, longevity, and weight-management peptide therapy.

Nevada cities Pepti serves

Pepti delivers BPC-157 + TB-500 (Injectable) to patients across Nevada, including Las Vegas, Henderson, Reno, North Las Vegas, Sparks, Carson City. All shipments use the same FDA-registered compounding pharmacy regardless of city.

Your protocol

How BPC-157 + TB-500 is prescribed in Nevada.

Who it's for

  • Adults who want both peptides in one injection for a recovery protocol
  • Patients with a significant injury or post-surgical recovery their physician is managing
  • Active adults managing more than one problem area

Your physician decides whether BPC-157 + TB-500 is appropriate for you after reviewing your intake and labs.

Directions & duration

Inject 0.25 mL (25 units) subcutaneously Monday through Friday mornings.

Cycle. Ongoing monthly treatment. Most patients notice the most change in the first two months and continue for lasting support.
Ready for more? When you're ready for more, ask your physician to move you up to the next strength. Approved steps are charged at the price difference and applied to your next fill.
Directions shown are the pharmacy's standard for this preparation. Your prescription label is the final word.

What's included

  • Licensed physician review of your intake, history, and labs
  • Medication compounded to your prescription by a PCAB-accredited, FDA-registered pharmacy
  • Every batch independently tested before release
  • Sterile syringes and alcohol prep pads for injectables
  • Tracked delivery to your door, refills on schedule
  • Message your physician anytime; dose changes without an appointment

Storage & handling

  • Store refrigerated (36–46°F / 2–8°C) at all times, including before first use.
  • One vial is your monthly supply. A fresh vial ships to your Nevada address every 28 days on your refill schedule, so you're always well inside the beyond-use date on your label.
  • Protect from light. Wipe the stopper with an alcohol pad before every draw.
  • Dispose of syringes in the sharps container per the included instructions.

What to expect

A typical course of BPC-157 + TB-500 in Nevada.

TimeframeWhat patients commonly report
Weeks 1–2Many patients report less soreness and easier movement in the injured or inflamed area.
Weeks 3–6Recovery-focused changes tend to build with consistent daily use; this is where most patients notice the difference.
Weeks 6–12 and onRecovery benefits tend to hold with continued use. Many patients stay on it long term for ongoing support, with the dose adjusted by their physician.
Individual results vary. Compounded medications are not FDA-approved; a licensed physician determines whether treatment is appropriate and monitors your progress.

The science

How BPC-157 + TB-500 works, and what the research shows.

How it works

Combines BPC-157 (local tissue repair) with TB-500 (Thymosin Beta-4, systemic cell migration and tissue regeneration).

The two peptides work in tandem — BPC-157 handles localized healing while TB-500 mobilizes repair cells throughout the body.

Clinical evidence

  • Each component carries its own preclinical record: BPC-157 has shown accelerated tendon-to-bone and Achilles healing in animal models, while Thymosin Beta-4 promoted cardiac and wound repair in landmark animal work and has been studied in human wound-healing trials.

    Chang et al., J Appl Physiol 2011; Krivic et al., J Orthop Res 2006Bock-Marquette et al., Nature 2004
  • The combination itself has not been tested in human clinical trials — it is prescribed off-label by licensed physicians based on the component evidence.

Full references with PubMed links are listed further down the page.

References

  1. Chang CH, Tsai WC, Lin MS et al.. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration · J Appl Physiol (1985) (2011) · PMID 21030672
  2. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues · Trends Mol Med (2005) · PMID 16099219
  3. Hsieh MJ, Liu HT, Wang CN et al.. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation · J Mol Med (Berl) (2017) · PMID 27847966
  4. Staresinic M, Sebecic B, Patrlj L et al.. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth · J Orthop Res (2003) · PMID 14554208
  5. Brcic L, Brcic I, Staresinic M et al.. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing · J Physiol Pharmacol (2009) · PMID 20388964
  6. Staresinic M, Petrovic I, Novinscak T et al.. Effective therapy of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157 · J Orthop Res (2006) · PMID 16609979
  7. Novinscak T, Brcic L, Staresinic M et al.. Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat · Surg Today (2008) · PMID 18668315
  8. Seiwerth S, Rucman R, Turkovic B et al.. BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing · Curr Pharm Des (2018) · PMID 29998800
  9. Philp D, Kleinman HK. Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide · Ann N Y Acad Sci (2010) · PMID 20536453
  10. Bock-Marquette I, Saxena A, White MD et al.. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair · Nature (2004) · PMID 15565145
  11. Ruff D, Crockford D, Girardi G, Zhang Y. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers · Ann N Y Acad Sci (2010) · PMID 20536472
  12. Treadwell T, Kleinman HK, Crockford D et al.. The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients · Ann N Y Acad Sci (2012) · PMID 23050815
  13. Sosne G, Dunn SP, Kim C. Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial · Cornea (2015) · PMID 25826322
  14. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL et al.. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale · Pain (2001) · PMID 11690728

Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.

Pharmacy network accreditation

PCAB-accredited pharmacies on every order.

Every fulfillment runs through a PCAB-accredited pharmacy.

See the lab results
PCAB — Pharmacy Compounding Accreditation Board · Accredited
  • Rigorous third-party quality & safety inspections
  • Cleanliness and sterile processes
  • Proper ingredient sourcing
  • Accurate dosing and formulation
  • Staff training and procedures
  • Accredited by NABP & ACHC
Common questions

Frequently asked
about BPC-157 + TB-500 (Injectable) in Nevada.

Yes. BPC-157 + TB-500 (Injectable) is legal when prescribed by a physician licensed in Nevada and dispensed by an FDA-registered compounding pharmacy. Nevada permits telehealth prescribing by Nevada-licensed physicians under state telehealth law. Online intake review establishes the physician-patient relationship — no in-person visit is required for non-controlled medications.

33 more questions about Pepti, answered.

Pepti serves all of Nevada. A physician licensed in Nevada reviews every order within 4 hours, the prescription is compounded by a state-licensed, FDA-registered pharmacy, and it ships free and tracked to any Nevada street address. The price is the same as every other state.

Pepti operates in Nevada through licensed physician partnerships. Compounded medications are produced at FDA-registered 503A pharmacies. Treatment decisions are made by your prescribing physician.